References
- Bernier J, Cooper JS. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?. Oncologist 2005; 10: 215–24
- Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000; 88: 876–83
- Pignon JP, Bourhis J, Domenege C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative group. Meta-analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355: 949–55
- Kunkel M, Rechert TE, Benz P, Lehr HA, Jeong JH, Wieand S, et al. Overexpression of GLUT 1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003; 97: 1015–24
- Milligan JR, Ward JF. Yield of single-strand breaks due to attack on DNA by scavenger-derived radicals. Radiat Res 1994; 137: 295–9
- Takada Y, Hachiya M, Park SH, Osawa Y, Ozawa T, Akashi M. Role of reactive oxygen species in cells overexpressing manganese superoxide dismutase: mechanism for induction of radioresistance. Mol Cancer Res 2002; 1: 137–46
- Hanash S. Disease proteomics. Nature 2003; 422: 226–32
- Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol (Stockh) 1997; 117: 775–84
- Chang HW, , Kim SYYi SL, Son SH, Song DY, Moon SY, et al. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral Oncol <serial online> 2006. Available from: URL: http://www.sciencedirect.com
- Gevaert K, Vandekerckhove J. Protein identification methods in proteomics. Electrophoresis 2000; 21: 1145–54
- Phizicky E, Bastiaens PI, Zhu H, Synder M. Fields S. Protein analysis on a proteomic scale. Nature 2003; 422: 208–15
- Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. Clinical proteomics; translating benchside promise into bedside reality. Nature Rev Drug Discov 2002; 1: 683–95
- Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803–15
- Lindquist S. The heat shock response. Annu Rev Biochem 1986; 55: 1151–91
- Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453–6
- Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins; endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001; 286: 433–42
- Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775–94
- Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide – role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997; 272: 217–21
- Chae HZ, Robison K, Poole LB, Chrch G, Storz G, Rhee SG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain; alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 1994; 91: 7017–21
- Kang SW, Chae HJ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 1998; 273: 6297–302
- Shau H, Kim AT, Hedrick CC, Luism AJ, Tompkin C, Finney R, et al. Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic Biol 1997; 22: 497–507
- Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, et al. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 2000; 6: 4915–20
- Wong CM, Chun AC, Kok KH, Zhou Y, Fung PC, Kung HF, et al. Characterization of human and mouse peroxiredoxin IV: evidence for inhibition of Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal 2000; 2: 507–18
- Ali-Osman F, Brunner JM, Kutluk TM, Hess K. Prognostic significance of glutathione S-transferase π expression and subcellular localization in human gliomas. Clin Cancer Res 1997; 3: 2253–61
- Nishimura T, Newkirk K, Sessions RB, Andrews PA, Trock BJ, Rasmussen AA, et al. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer. Clin Cancer Res 1996; 2: 1859–65